Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer.

Lian L, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Gong FR, Tao M, Li W.

Oncol Lett. 2015 Dec;10(6):3419-3424. Epub 2015 Oct 8.

2.

Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer.

Wang F, Liu ZY, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR, Tao M, Lian L, Li W.

Oncol Lett. 2015 Dec;10(6):3411-3418. Epub 2015 Oct 8.

3.

Towards curative therapy in gastric cancer: Faraway, so close!

Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R.

World J Gastroenterol. 2015 Nov 7;21(41):11609-20. doi: 10.3748/wjg.v21.i41.11609. Review.

4.

Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer.

Pease NA, Wise-Draper T, Privette Vinnedge L.

J Oncol. 2015;2015:106517. doi: 10.1155/2015/106517. Epub 2015 Sep 6. Review.

5.

Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study.

Shebl FM, Hsing AW, Park Y, Hollenbeck AR, Chu LW, Meyer TE, Koshiol J.

PLoS One. 2014 Dec 31;9(12):e114633. doi: 10.1371/journal.pone.0114633. eCollection 2014.

6.

Gastric cancer: prevention, screening and early diagnosis.

Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M.

World J Gastroenterol. 2014 Oct 14;20(38):13842-62. doi: 10.3748/wjg.v20.i38.13842. Review.

7.

Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.

Shao Y, Sun K, Xu W, Li XL, Shen H, Sun WH.

World J Gastroenterol. 2014 Sep 28;20(36):12860-73. doi: 10.3748/wjg.v20.i36.12860. Review.

8.

No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis.

Zhang B, Liang X, Ye L, Wang Y.

PLoS One. 2014 May 14;9(5):e96887. doi: 10.1371/journal.pone.0096887. eCollection 2014.

9.

At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Dalal RS, Moss SF.

J Leukoc Biol. 2014 Aug;96(2):213-24. doi: 10.1189/jlb.4BT0214-100R. Epub 2014 May 13. Review.

10.
11.

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer.

Hong LZ, Wei XW, Chen JF, Shi Y.

Oncol Lett. 2013 Dec;6(6):1595-1603. Epub 2013 Sep 18.

13.

The Effect of Helicobacter pylori on Epidermal Growth Factor Receptor-Induced Signal Transduction and the Preventive Effect of Celecoxib in Gastric Cancer Cells.

Kim J, Kim N, Park JH, Chang H, Kim JY, Lee DH, Kim JM, Kim JS, Jung HC.

Gut Liver. 2013 Sep;7(5):552-9. doi: 10.5009/gnl.2013.7.5.552. Epub 2013 Aug 14.

14.

Circulating cytokines and gastric cancer risk.

Epplein M, Xiang YB, Cai Q, Peek RM Jr, Li H, Correa P, Gao J, Wu J, Michel A, Pawlita M, Zheng W, Shu XO.

Cancer Causes Control. 2013 Dec;24(12):2245-50. doi: 10.1007/s10552-013-0284-z. Epub 2013 Sep 20.

15.

Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer.

Cover TL, Peek RM Jr.

Gut Microbes. 2013 Nov-Dec;4(6):482-93. doi: 10.4161/gmic.26262. Epub 2013 Sep 3. Review.

16.

Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.

Ye X, Fu J, Yang Y, Gao Y, Liu L, Chen S.

PLoS One. 2013 Jul 30;8(7):e71522. doi: 10.1371/journal.pone.0071522. Print 2013. Review.

17.

Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells.

Sierra JC, Hobbs S, Chaturvedi R, Yan F, Wilson KT, Peek RM Jr, Polk DB.

Am J Physiol Gastrointest Liver Physiol. 2013 Jul 15;305(2):G196-203. doi: 10.1152/ajpgi.00495.2012. Epub 2013 May 16.

18.

Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?

Sjödahl K, Lagergren J.

EPMA J. 2010 Sep;1(3):461-71. doi: 10.1007/s13167-010-0043-0. Epub 2010 Jul 22.

19.

Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations.

Bonelli P, Tuccillo FM, Federico A, Napolitano M, Borrelli A, Melisi D, Rimoli MG, Palaia R, Arra C, Carinci F.

Int J Nanomedicine. 2012;7:5683-91. doi: 10.2147/IJN.S34723. Epub 2012 Nov 9.

20.

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva.

Endoscopy. 2012 Jan;44(1):74-94. doi: 10.1055/s-0031-1291491. Epub 2011 Dec 23.

Items per page

Supplemental Content

Write to the Help Desk